Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	IPO	Common Stock	Common Stock IPO	Additional Paid-In Capital	Additional Paid-In Capital IPO	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Balance at Dec. 31, 2021	$ 178,783		$ 3		$ 228,532		$ (10)	$ (49,742)
Balance (in shares) at Dec. 31, 2021			29,115,421
Issuance of restricted stock (in shares)			186,727
Exercise of stock options	516				516
Exercise of stock options, (in shares)			81,067
Purchases under employee stock purchase plan	723				723
Purchases under employee stock purchase plan (in shares)			178,339
Stock-based compensation expense	10,336				10,336
Unrealized gain (loss) on investments, net	9						9
Net loss	(81,828)							(81,828)
Balance at Dec. 31, 2022	108,539		$ 3		240,107		(1)	(131,570)
Balance (in shares) at Dec. 31, 2022			29,561,554
Issuance of common stock, public offering		$ 161,803		$ 1		$ 161,802
Issuance of common stock, public offering (in shares)				5,750,000
Issuance of restricted stock (in shares)			180,316
Exercise of stock options	937				937
Exercise of stock options, (in shares)			125,192
Purchases under employee stock purchase plan	1,081				1,081
Purchases under employee stock purchase plan (in shares)			249,548
Stock-based compensation expense	14,131				14,131
Unrealized gain (loss) on investments, net	1						$ 1
Net loss	(117,255)							(117,255)
Balance at Dec. 31, 2023	169,237		$ 4		418,058			(248,825)
Balance (in shares) at Dec. 31, 2023			35,866,610
Issuance of restricted stock (in shares)			109,356
Exercise of stock options	$ 518				518
Exercise of stock options, (in shares)	106,339		106,339
Purchases under employee stock purchase plan	$ 1,150				1,150
Purchases under employee stock purchase plan (in shares)			228,408
Stock-based compensation expense	19,094				19,094
Net loss	(138,426)							(138,426)
Balance at Dec. 31, 2024	$ 51,573		$ 4		$ 438,820			$ (387,251)
Balance (in shares) at Dec. 31, 2024			36,310,713